CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Sanofi v. Unimark Remedies Ltd.

1:14-cv-00876

Overview

Case Number 1:14-cv-00876
Filing Date 2014-07-03
Status Terminated
Termination Date 2015-02-20
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Unimark Remedies Ltd. Operating Company

Represented By

3 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Jeffrey S. Ward

Email: jward@nge.com

Richard L. Horwitz

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Sanofi Operating Company

Represented By

2 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Plaintiff

Sanofi-Aventis US LLC Operating Company

Represented By

2 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 6 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): FR πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (6 found):
U.S. Courts: 6
U.S. District Court 2014-11-24
1:14-cv-01434

Sanofi v. Sandoz Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-07-03
1:14-cv-00875

Sanofi v. Amneal Pharmaceuticals LLC

Asserted Patent
Status: DED
U.S. District Court 2014-04-04
1:14-cv-00424

Sanofi v. Alembic Pharmaceuticals Limited

Asserted Patent
Status: DED
U.S. District Court 2014-03-06
1:14-cv-00293

Sanofi v. First Time US Generics LLC

Asserted Patent
Status: DED
U.S. District Court 2014-03-06
1:14-cv-00292

Sanofi v. Alkem Laboratories Ltd.

Asserted Patent
Status: DED
U.S. District Court 2014-03-06
1:14-cv-00294

Sanofi v. Sun Pharma Global FZE

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

4 Patents

There are 4 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7323493
Solid pharmaceutical composition containing benzofuran derivatives
Filed: 1998-06-19
Issued: 2008-01-29
Expired (Term Ended)
Expires: 2018-06-19
US8318800
Solid pharmaceutical compositions containing benzofuran derivatives
Filed: 2007-12-13
Issued: 2012-11-27
Expired (Term Ended)
Expires: 2019-06-15
US8410167
Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality
Filed: 2009-04-16
Issued: 2013-04-02
Active (2.4 yrs remaining)
Expires: 2029-04-16
US8602215
Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation
Filed: 2011-06-30
Issued: 2013-12-10
Active (4.6 yrs remaining)
Expires: 2031-06-30

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

6

Dispositive

0

Granted

0

Denied

0

Pending / Review

3

Motions by Category

Procedural / Extension Motion 6

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Plaintiffs' Complaint to September 24, 2014 - filed by Sanofi, Sanofi-Aventis US LLC. (Fahne...
Entry #9 • 2014-09-02 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 9 STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Complaint to September 24, 2014, filed by Sanofi-Aventis US LLC, Sanofi (Re...
Entry #β€” • 2014-09-02
Procedural / Extension Motion Pending
SO ORDERED, re 8 STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Plaintiffs' Complaint to September 3, 2014, filed by Sanofi-Aventis US LLC,...
Entry #β€” • 2014-08-13
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Plaintiffs' Complaint to September 3, 2014 - filed by Sanofi, Sanofi-Aventis US LLC. (Fahnes...
Entry #8 • 2014-08-12 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 7 STIPULATION TO EXTEND TIME to answer Complaint to August 13, 2014, filed by Sanofi-Aventis US LLC, Sanofi (Reset Answer Deadlines: Unimark Reme...
Entry #β€” • 2014-07-30
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to answer Complaint to August 13, 2014 - filed by Sanofi, Sanofi-Aventis US LLC. (Fahnestock, Derek) (Entered: 07/29/2014)
Entry #7 • 2014-07-29 Document →

Docket Entries

(42 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Unimark Remedies Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1547599.) - filed by Sanofi-Aventis US LLC, Sanofi. (Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet)(cla, ) (Entered: 07/07/2014)

Entry #1 • 2014-07-03
1
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Unimark Remedies Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1547599.) - filed by Sanofi-Aventis US LLC, Sanofi. (Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet)(cla, ) (Entered: 07/07/2014)

Entry #1 • 2014-07-03
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Unimark Remedies Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1547599.) - filed by Sanofi-Aventis US LLC, Sanofi. (Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet)(cla, ) (Entered: 07/07/2014)

Entry #1 • 2014-07-03
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cla, ) (Entered: 07/07/2014)

Entry #2 • 2014-07-03
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/24/14. Date of Expiration of Patent: SEE FORM.Thirty Month Stay Deadline: 1/1/2017. (cla, ) (Entered: 07/07/2014)

Entry #3 • 2014-07-03
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc